Showing results (551-560 of 602) with videos related to

Sort By:
Pageof 61
Blood|September 19, 2008
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxisLucy A Truman, Catriona A Ford, Marta Pasikowska, et al.
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|August 15, 2018
Mechanical Anisotropy Assessment in Kidney Cortex Using ARFI Peak Displacement: Preclinical Validation and Pilot In Vivo Clinical Results in Kidney AllograftsMd Murad Hossain, Randal K Detwiler, Emily H Chang, et al.
Genome Biology|October 3, 2022
H3K18 lactylation marks tissue-specific active enhancersEva Galle, Chee-Wai Wong, Adhideb Ghosh, et al.
Human Molecular Genetics|June 8, 2018
Cofilin-1 phosphorylation catalyzed by ERK1/2 alters cardiac actin dynamics in dilated cardiomyopathy caused by lamin A/C gene mutationMaria Chatzifrangkeskou, David Yadin, Thibaut Marais, et al.
Parasites & Vectors|January 15, 2013
Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011Patricia M Graves, Leo Makita, Melinda Susapu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 8, 2006
Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalinMark J Field, Peter J Cox, Emma Stott, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Bowman birk inhibitor concentrate and oral leukoplakia: a randomized phase IIb trialWilliam B Armstrong, Thomas H Taylor, Ann R Kennedy, et al.
Neurogenetics|January 17, 2007
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor, Mary M Hulihan, Jennifer M Kachergus, et al.
The Biochemical Journal|April 9, 2013
Comprehensive characterization and optimization of anti-LRRK2 (leucine-rich repeat kinase 2) monoclonal antibodiesPaul Davies, Kelly M Hinkle, Nour N Sukar, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 2025
Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet functionYiheng Zhang, Chih-Jen Yang, Alexander R Melrose, et al.
Pageof 61